Novavax | NVAX - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
Adma Biologics USD 50.4M 8.24M 2025-12
Agenus USD 642K 399K 2025-09
AstraZeneca USD 3.27B 471M 2025-12
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Cassava Sciences USD 3.96M 1.16M 2025-09
Geron USD 1.31M 263K 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
MannKind USD 33.65M 13.44M 2025-12
Merck USD 3.32B 531M 2025-12
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 452M 245M 2025-12
Novartis USD 3.54B 7M 2025-12
Novavax USD 22.1M 608K 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
TG Therapeutics USD 38.14M 10.05M 2025-12